Probiotics for the prevention of pediatric upper respiratory tract infections: a systematic review

Metehan Ozen1, Gonca Kocabas Sandal, Ener Cagri Dinleyici

  • 1Department of Pediatrics, Acibadem University Faculty of Medicine , Istanbul , Turkey.

Insights

Prophylactic probiotic use in children modestly reduces the incidence and severity of acute upper respiratory tract infections (URTIs). Long-term administration of probiotics is safe for children, showing no serious adverse events.

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiome Research
  • Public Health

Background:

  • Acute upper respiratory tract infections (URTIs) are a major cause of illness in children globally.
  • Preventing URTIs in childhood is a significant public health concern.
  • Previous reviews suggest probiotics may be beneficial for URTIs, but evidence is limited.

Purpose of the Study:

  • To evaluate the efficacy of prophylactic probiotic use in preventing URTIs in children.
  • To focus specifically on the pediatric population for probiotic intervention in URTIs.

Main Methods:

  • Systematic review of 14 high-quality randomized controlled trials (RCTs) from two databases (inception to June 2014).
  • Focused on Lactobacillus and Bifidobacterium strains for their effects on URTI incidence and symptom scores in healthy children.
  • Data extraction and quality assessment performed by two independent reviewers.

Main Results:

  • Probiotics demonstrate a modest effect in reducing both the incidence and symptom severity of URTIs in immunocompetent children.
  • The review provides the first comprehensive evaluation of specific probiotic strains for URTI prevention in pediatric populations.

Conclusions:

  • Prophylactic probiotic administration showed at least one beneficial effect in most RCTs.
  • Even a small reduction in URTI incidence (5-10%) has significant clinical and economic implications.
  • Long-term probiotic use in childhood is safe, with no reported serious adverse events.
Abstract

Related Concept Videos

Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: First and Second-Generation Antihistamines01:15

Upper Respiratory Drugs: First and Second-Generation Antihistamines

Antihistamines are a class of drugs widely used to alleviate the symptoms of allergies, such as sneezing, itching, and nasal congestion. They work by inhibiting the actions of histamine, which is released by immune cells in response to allergenic substances or tissue injuries.
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...